Article

Risks of Opioid Use by Elderly Arthritic Patients Outweigh Benefits

Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so great.

Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so great, according to a review of previous studies.

Related Videos
HCPLive Five at Maui Derm NP+PA Fall 2024 | Image Credit: HCPLive
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Benjamin Scirica, MD | Credit: Brigham and Women's Hospital
Nihar Desai, MD | Credit: HCPLive.com
Laurence Sperling, MD | Credit: Emory University
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Related Content
Crisugabalin Provides Significant Pain Improvements in Adults with Postherpetic Neuralgia
October 4th 2024

Crisugabalin Provides Significant Pain Improvements in Adults with Postherpetic Neuralgia

Chelsie Derman
Default thumbnail for Diabetes Dialogue, featuring podcast logo and headshots of hosts.
April 17th 2024

Diabetes Dialogue: STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
investigator Dr Nam Huynh, senior research fellow, UCL Medical Physics and Biomedical Engineering
October 3rd 2024

Rapid, High-Fidelity Medical Imaging Reveals Cancer, Arthritis in New Research

Victoria Johnson
"New Insight with Veeral Sheth, MD" logo | Image Credit: HCPLive
February 29th 2024

New Insight: Role of Contract Research Organizations in Retina w/ Brad Doerschuk

Connor Iapoce
Rahul Aggarwal, MD | Credit: LinkedIn
October 2nd 2024

If Successful, Inclisiran Primary Prevention Trial Could Expand Patient Population by More than 22 Million

Patrick Campbell
Megan Hanlon, PhD, former post-doctoral fellow in molecular rheumatology, Trinity College Dublin, Brigham and Women's, Harvard University
October 2nd 2024

New Research Identifies Predictive Changes in Joint Microenviroment Prior to RA Onset

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.